Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Alicia Shugart is active.

Publication


Featured researches published by Alicia Shugart.


Morbidity and Mortality Weekly Report | 2017

Notes from the Field: Ongoing Transmission of Candida auris in Health Care Facilities — United States, June 2016–May 2017

Sharon Tsay; Rory M. Welsh; Eleanor Adams; Nancy A. Chow; Lalitha Gade; Elizabeth L. Berkow; Eugenie Poirot; Emily Lutterloh; Monica Quinn; Sudha Chaturvedi; Janna L Kerins; Stephanie Black; Sarah Kemble; Patricia M Barrett; Kerri Barton; Dj Shannon; Kristy K Bradley; Shawn R. Lockhart; Anastasia P. Litvintseva; Heather Moulton-Meissner; Alicia Shugart; Alex Kallen; Snigdha Vallabhaneni; Tom Chiller; Brendan R. Jackson

Ongoing Transmission of Candida auris in Health Care Facilities — United States, June 2016–May 2017 Sharon Tsay, MD1,2; Rory M. Welsh, PhD1; Eleanor H. Adams, MD3; Nancy A. Chow, PhD1; Lalitha Gade, MPharm1; Elizabeth L. Berkow, PhD1; Eugenie Poirot, PhD2,4; Emily Lutterloh, MD3,5; Monica Quinn, MS3; Sudha Chaturvedi, PhD3,5; Janna Kerins, VMD2,6; Stephanie R. Black, MD6; Sarah K. Kemble, MD6; Patricia M. Barrett, MSD7; Kerri Barton, MPH8; D.J. Shannon, MPH9; Kristy Bradley, DVM10; Shawn R. Lockhart, PhD1; Anastasia P. Litvintseva, PhD1; Heather MoultonMeissner, PhD11; Alicia Shugart, MA11; Alex Kallen, MD11; Snigdha Vallabhaneni, MD1; Tom M. Chiller, MD1; Brendan R. Jackson, MD1


Health Communication | 2014

Social Influence in Child Care Centers: A Test of the Theory of Normative Social Behavior

Maria Knight Lapinski; Jenn Anderson; Alicia Shugart; Ewen C. D. Todd

Child care centers are a unique context for studying communication about the social and personal expectations about health behaviors. The theory of normative social behavior (TNSB; Rimal & Real, 2005) provides a framework for testing the role of social and psychological influences on handwashing behaviors among child care workers. A cross-sectional survey of child care workers in 21 centers indicates that outcome expectations and group identity increase the strength of the relationship between descriptive norms and handwashing behavior. Injunctive norms also moderate the effect of descriptive norms on handwashing behavior such that when strong injunctive norms are reported, descriptive norms are positively related to handwashing, but when weak injunctive norms are reported, descriptive norms are negatively related to handwashing. The findings suggest that communication interventions in child care centers can focus on strengthening injunctive norms in order to increase handwashing behaviors in child care centers. The findings also suggest that the theory of normative social behavior can be useful in organizational contexts.


Clinical Journal of The American Society of Nephrology | 2017

National Healthcare Safety Network (NHSN) Dialysis Event Surveillance Report for 2014

Duc B. Nguyen; Alicia Shugart; Christi Lines; Ami B. Shah; Jonathan R. Edwards; Daniel A. Pollock; Dawn M. Sievert; Priti R. Patel

BACKGROUND AND OBJECTIVES Persons receiving outpatient hemodialysis are at risk for bloodstream and vascular access infections. The Centers for Disease Control and Prevention conducts surveillance for these infections through the National Healthcare Safety Network. We summarize 2014 data submitted to National Healthcare Safety Network Dialysis Event Surveillance. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS Dialysis facilities report three types of dialysis events (bloodstream infections; intravenous antimicrobial starts; and pus, redness, or increased swelling at the hemodialysis vascular access site). Denominator data consist of the number of hemodialysis outpatients treated at the facility during the first 2 working days of each month. We calculated dialysis event rates stratified by vascular access type (e.g., arteriovenous fistula, arteriovenous graft, or central venous catheter) and standardized infection ratios (comparing individual facility observed with predicted numbers of infections) for bloodstream infections. We described pathogens identified among bloodstream infections. RESULTS A total of 6005 outpatient hemodialysis facilities reported dialysis event data for 2014 to the National Healthcare Safety Network. These facilities reported 160,971 dialysis events, including 29,516 bloodstream infections, 149,722 intravenous antimicrobial starts, and 38,310 pus, redness, or increased swelling at the hemodialysis vascular access site events; 22,576 (76.5%) bloodstream infections were considered vascular access related. Most bloodstream infections (63.0%) and access-related bloodstream infections (69.8%) occurred in patients with a central venous catheter. The rate of bloodstream infections per 100 patient-months was 0.64 (0.26 for arteriovenous fistula, 0.39 for arteriovenous graft, and 2.16 for central venous catheter). Other dialysis event rates were also highest among patients with a central venous catheter. Facility bloodstream infection standardized infection ratio distribution was positively skewed with a median of 0.84. Staphylococcus aureus was the most commonly isolated bloodstream infection pathogen (30.6%), and 39.5% of S. aureus isolates tested were resistant to methicillin. CONCLUSIONS The 2014 National Healthcare Safety Network Dialysis Event data represent nearly all United States outpatient dialysis facilities. Rates of infection and other dialysis events were highest among patients with a central venous catheter compared with other vascular access types. Surveillance data can help define the epidemiology of important infections in this patient population.


American Journal of Infection Control | 2016

Dialysis Event Surveillance Report: National Healthcare Safety Network data summary, January 2007 through April 2011.

Priti R. Patel; Alicia Shugart; Chukwuma Mbaeyi; Ann Goding Sauer; Anna Melville; Duc B. Nguyen

A total of 24,092 adverse events in hemodialysis outpatients during January 2007 through April 2011 were reported to the National Healthcare Safety Network. Of 2,656 bloodstream infections, 67.3% were in patients with central venous catheters. For all events, rates associated with central venous catheters were higher than for other vascular access types.


Infection Control and Hospital Epidemiology | 2012

A Qualitative Assessment of a Performance Measure for Reporting Influenza Vaccination Rates among Healthcare Personnel

Taranisia MacCannell; Alicia Shugart; Amy Schneider; Megan C. Lindley; Suchita A. Lorick; Agam K Rao; LaDora O. Woods; Faruque Ahmed; Ronda L. Sinkowitz-Cochran

To understand the feasibility of implementing a standardized performance measure for collecting and reporting influenza vaccination rates among healthcare personnel, qualitative, semistructured interviews were conducted with key informants in 32 healthcare facilities. Despite practical and logistical challenges to implementing the measure, respondents perceived clear benefits to its use.


Infection Control and Hospital Epidemiology | 2016

Sustained Infection Reduction in Outpatient Hemodialysis Centers Participating in a Collaborative Bloodstream Infection Prevention Effort.

Sarah H. Yi; Sally Hess; Virginia Bren; Mary Lincoln; Gemma Downham; Karen Kelley; Stephanie Booth; Heather Weirich; Alicia Shugart; Christi Lines; Anna Melville; John A. Jernigan; David Kleinbaum; Priti R. Patel

Among dialysis facilities participating in a bloodstream infection (BSI) prevention collaborative, access-related BSI incidence rate improvements observed immediately following implementation of a bundle of BSI prevention interventions were sustained for up to 4 years. Overall, BSI incidence remained unchanged from baseline in the current analysis. Infect Control Hosp Epidemiol 2016;37:863-866.


Infection Control and Hospital Epidemiology | 2016

Completeness of Methicillin-Resistant Staphylococcus aureus Bloodstream Infection Reporting From Outpatient Hemodialysis Facilities to the National Healthcare Safety Network, 2013.

Duc B. Nguyen; Isaac See; Nicole Gualandi; Alicia Shugart; Christi Lines; Wendy Bamberg; Ghinwa Dumyati; Lee H. Harrison; Lindsey Lesher; Joelle Nadle; Susan Petit; Susan M. Ray; William Schaffner; John M. Townes; Levi Njord; Dawn M. Sievert; Nicola D. Thompson; Priti R. Patel

Reports of bloodstream infections caused by methicillin-resistant Staphylococcus aureus among chronic hemodialysis patients to 2 Centers for Disease Control and Prevention surveillance systems (National Healthcare Safety Network Dialysis Event and Emerging Infections Program) were compared to evaluate completeness of reporting. Many methicillin-resistant S. aureus bloodstream infections identified in hospitals were not reported to National Healthcare Safety Network Dialysis Event.


Morbidity and Mortality Weekly Report | 2018

Vital Signs : Containment of novel multidrug-resistant organisms and resistance mechanisms — United States, 2006–2017

Kate Woodworth; Maroya Spaldin Walters; Lindsey M. Weiner; Jonathan R. Edwards; Allison C. Brown; Jennifer Y. Huang; Sarah Malik; Rachel B. Slayton; Prabasaj Paul; Catherine Capers; Marion Kainer; Nancy Wilde; Alicia Shugart; Garrett Mahon; Jean B. Patel; L. Clifford McDonald; Arjun Srinivasan; Michael Craig; Denise M. Cardo

Background Approaches to controlling emerging antibiotic resistance in health care settings have evolved over time. When resistance to broad-spectrum antimicrobials mediated by extended-spectrum β-lactamases (ESBLs) arose in the 1980s, targeted interventions to slow spread were not widely promoted. However, when Enterobacteriaceae with carbapenemases that confer resistance to carbapenem antibiotics emerged, directed control efforts were recommended. These distinct approaches could have resulted in differences in spread of these two pathogens. CDC evaluated these possible changes along with initial findings of an enhanced antibiotic resistance detection and control strategy that builds on interventions developed to control carbapenem resistance. Methods Infection data from the National Healthcare Safety Network from 2006–2015 were analyzed to calculate changes in the annual proportion of selected pathogens that were nonsusceptible to extended-spectrum cephalosporins (ESBL phenotype) or resistant to carbapenems (carbapenem-resistant Enterobacteriaceae [CRE]). Testing results for CRE and carbapenem-resistant Pseudomonas aeruginosa (CRPA) are also reported. Results The percentage of ESBL phenotype Enterobacteriaceae decreased by 2% per year (risk ratio [RR] = 0.98, p<0.001); by comparison, the CRE percentage decreased by 15% per year (RR = 0.85, p<0.01). From January to September 2017, carbapenemase testing was performed for 4,442 CRE and 1,334 CRPA isolates; 32% and 1.9%, respectively, were carbapenemase producers. In response, 1,489 screening tests were performed to identify asymptomatic carriers; 171 (11%) were positive. Conclusions The proportion of Enterobacteriaceae infections that were CRE remained lower and decreased more over time than the proportion that were ESBL phenotype. This difference might be explained by the more directed control efforts implemented to slow transmission of CRE than those applied for ESBL-producing strains. Increased detection and aggressive early response to emerging antibiotic resistance threats have the potential to slow further spread.


Infection Control and Hospital Epidemiology | 2018

Hospital microbiology laboratory practices for Enterobacteriaceae: Centers for Disease Control and Prevention National Healthcare Safety Network (NHSN) annual survey, 2015 and 2016

Alicia Shugart; Maroya Spalding Walters; Lindsey M. Weiner; David Lonsway

We analyzed clinical microbiology laboratory practices for detection of multidrug-resistant Enterobacteriaceae in US short-stay acute-care hospitals using data from the National Healthcare Safety Network (NHSN) Annual Facility Survey. Half of hospitals reported testing for carbapenemases, and 1% performed routine polymyxin susceptibility testing using reference broth microdilution.


Clinical Infectious Diseases | 2018

Transmission of Mobile Colistin Resistance (mcr-1) by Duodenoscope

Erica S. Shenoy; Virginia M. Pierce; Maroya Spalding Walters; Heather Moulton-Meissner; Adrian Lawsin; David Lonsway; Alicia Shugart; Gillian McAllister; Alison Laufer Halpin; Alejandra Zambrano-Gonzalez; Erin E Ryan; Dolores Suslak; Alexandra DeJesus; Kerri Barton; Lawrence C. Madoff; Eileen McHale; Alfred DeMaria; David C. Hooper

BACKGROUND Clinicians increasingly utilize polymyxins for treatment of serious infections caused by multidrug-resistant gram-negative bacteria. Emergence of plasmid-mediated, mobile colistin resistance genes creates potential for rapid spread of polymyxin resistance. We investigated the possible transmission of Klebsiella pneumoniae carrying mcr-1 via duodenoscope and report the first documented healthcare transmission of mcr-1-harboring bacteria in the United States. METHODS A field investigation, including screening targeted high-risk groups, evaluation of the duodenoscope, and genome sequencing of isolated organisms, was conducted. The study site included a tertiary care academic health center in Boston, Massachusetts, and extended to community locations in New England. RESULTS Two patients had highly related mcr-1-positive K. pneumoniae isolated from clinical cultures; a duodenoscope was the only identified epidemiological link. Screening tests for mcr-1 in 20 healthcare contacts and 2 household contacts were negative. Klebsiella pneumoniae and Escherichia coli were recovered from the duodenoscope; neither carried mcr-1. Evaluation of the duodenoscope identified intrusion of biomaterial under the sealed distal cap; devices were recalled to repair this defect. CONCLUSIONS We identified transmission of mcr-1 in a United States acute care hospital that likely occurred via duodenoscope despite no identifiable breaches in reprocessing or infection control practices. Duodenoscope design flaws leading to transmission of multidrug-resistant organsisms persist despite recent initiatives to improve device safety. Reliable detection of colistin resistance is currently challenging for clinical laboratories, particularly given the absence of a US Food and Drug Administration-cleared test; improved clinical laboratory capacity for colistin susceptibility testing is needed to prevent the spread of mcr-carrying bacteria in healthcare settings.

Collaboration


Dive into the Alicia Shugart's collaboration.

Top Co-Authors

Avatar

Priti R. Patel

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Duc B. Nguyen

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Christi Lines

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Isaac See

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Kerri Barton

Massachusetts Department of Public Health

View shared research outputs
Top Co-Authors

Avatar

Anastasia P. Litvintseva

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Anna Melville

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Brendan R. Jackson

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

David Lonsway

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Dawn M. Sievert

Centers for Disease Control and Prevention

View shared research outputs
Researchain Logo
Decentralizing Knowledge